ISPOR/ISPE Summit on

Real-World Evidence in Health Care Decision Making

Date: October 20, 2017

Location: Washington, DC, USA

Venue: Grand Hyatt Hotel

Conference Description

ISPOR and ISPE have collaborated on a joint task force to produce coordinated papers that make specific recommendations for improving the transparency and reproducibility of real-world evidence for use in health care decision making–especially those decisions at the regulatory and payer levels. This 1-day Summit will provide a forum for reviewing these task force reports, considering the perspectives of key stakeholders, and discussing future steps that could help enable these recommendations.

Final Presentation Slides

Conference Program
7:30 AM
Registration
9:00 AM
Welcome and Introduction
Speaker: Nancy Berg, ISPOR CEO
ISPOR, Lawrenceville, NJ, USA
Bio
9:15 AM
Keynote Address
 
Harold Sox
Speaker: Harold Sox, MD
PCORI, Washington, DC, USA
Bio
9:30 AM
FRAMING THE PROBLEM & PRESENTATION OF RECOMMENDATIONS
Transparency Issues
Marc Berger
Speaker: Marc Berger, MD
Pfizer, New York, NY, USA
Bio
Reproducibility Issues
Sebastian Schneeweiss
Speaker: Sebastian Schneeweiss, MD, ScD, FISPE
Harvard Medical School, Boston, MA, USA
Bio
Transparency Recommendations
Daniel Mullins
Speaker: C. Daniel Mullins, PhD
University of Maryland, Baltimore, MD, USA
Bio
Reproducibility Recommendations
Shirley Wang
Speaker: Shirley Wang, PhD, MSc
Harvard Medical School, Boston, MA, USA
Bio
10:40 AM
Break
11:00 AM
Regulatory/HTA Reactions
 
Richard Willke
Moderator: Richard Willke, PhD
ISPOR, Lawrenceville, NJ, USA
Bio
US Regulatory

Speakers:

Jacqueline Corrigan-Curay
Jacqueline Corrigan-Curay, MD
US Food and Drug Administration, Washington, DC, USA
Bio
Robert Ball
Robert Ball, MD, MPH, ScM
CDER, US Food and Drug Administration, Washington, DC, USA
Bio
EUnetHTA
Wim Goettsch
Speaker: Wim Goettsch, PhD
EuNetHTA JA3, Diemen, The Netherlands
Bio
US Payer
Laura Happe
Speaker: Laura Happe, PharmD, MPH
Humana, Louisville, KY, USA
Bio
12:00 PM
Lunch
1:10 PM
Afternoon Sessions – Welcome
 
Tobias Gerhard
Speaker: Tobias Gerhard, PhD, FISPE, (ISPE)E
Rutgers University, New Brunswick, NJ, USA
Bio
1:15 PM
Other key stakeholder perspectives
 
Tobias Gerhard
Speaker: Tobias Gerhard, PhD, FISPE, (ISPE)
Rutgers University, New Brunswick, NJ, USA
Bio
Patient representative
Eric Gascho
Speaker: Eric Gascho
National Health Council, Washington, DC, USA
Bio
Registry representative
Deborah Zarin
Speaker: Deborah Zarin, MD
National Institutes of Health, Bethesda, MD, USA
Bio
Industry representative
Cathy Critchlow
Speaker: Cathy Critchlow, PhD
Amgen, Thousand Oaks, CA, USA
Bio
2:15 PM
Medical Editor Panel
 
Daniel Mullins
Moderator: C. Daniel Mullins, PhD, Value in Health
Bio

Speakers:

Elizabeth Loder Elizabeth Loder, MD, MPH, The BMJ
Bio
Laura Happe Laura Happe, PharmD, MPH, Journal of Managed Care & Specialty Pharmacy
Bio
Brian Strom Brian Strom, MD, MPH, FISPE, Pharmacoepidemiology and Drug Safety
Bio
Harold Sox Harold Sox, MD, formerly Annals of Internal Medicine
Bio
3:15 PM
Closing remarks
 
Richard Willke
Speaker: Richard Willke, PhD
ISPOR, Lawrenceville, NJ, USA
Bio
3:30 PM
Adjourn
Program
20-20 October 2017   Add to calendar
Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.